• Reduced all-cause mortality with statin use hazard ratio (HR) 0.63 (95% CI 0.48–0.84)
• Patients on ACEi/ARB therapy in addition to statin did not have increased mortality compared to statin alone
• Statin therapy not associated with acute cardiac injury
• Inflammatory markers CRP, IL-6 were lower in statin treated patients while in hospital